New Tools in Therapeutic Research—Prostatic Cancer and Models

Allen NE , Appleby PN , Davey GK , Key TJ (2000). Hormones and diet: Low insulin-like growth factor-I but normal bioavailabl e androgen s in vegan men. Br J Cancer 83: 95—97.

Allen NE , Forrest MS , Key TJ (2001). The association between polymorphisms in the CYP17 and 5-alpha-reductase (SRD5A2) genes and serum androgen concentrations in men. Cancer Epidemiol Biomarkers Prev 10: 185—189.

Bosland MC (1992 ). Animal models for the study of prostate carcinogenesis . J Cell Biochem (Suppl) 16H: 89—98.

Bosland MC (1999). Use of animal models in defi ning effi cacy of chemoprevention agents against prostate cancer. Eur Urol 35: 459—463.

Bosland MC , Ford H. , Horton L. (1995). Induction at high incidence of ductal prostate adenocarcinomas in NBL/Cr and Sprague—Dawley Hsd:SD rats treated with a combination of testosterone and estradiol-17 beta or diethylstilbestrol . Carcinogenesis 16: 1311—1317.

Bosland MC , Walden PD , Taneja S. (1999). Animal and tissue culture models of prostate cancer . In: Prostate Diseases , Lepor H (ed). WB Saunders, Philadelphia, pp 357—370.

BostwickDG , Ramnani D. , Qian J. ( 2000). Prostatic intraepithelial neoplasia: Animal models. Prostate 43: 286—294.

BubendorfL , Kononen J. , Koivisto P. , Schraml P. , Moch H. , Gassser TC , Willi N. , Mihatsch MJ , Sauter G. , Kallioniemi OP (1999). Survey of gene amplifi- cations during prostate cancer progression by high-throughput fluorescence in situ hybridization on tissue microarrays. Cancer Res 59: 803—806.

Burgess JK , Hazelton RH (2000). New developments in the analysis of gene expression . Redox Rep 5: 63—73.

DiGiovanni J. , Kiguchi K. , Frijhoff A. , Wilker E. , Bol DK , Beltran L. , Moats S. , Ramirez A. , Jorcano J. , Conti C. (2000). Deregulated expression of insulin-like growth factor I in prostate epithelium leads to neoplasia in transgenic mice. Proc Natl Acad Sci USA 97: 3455—3460.

Eisenberger MA , Simon R. , O'Dwyer PJ , Wittes RE , Friedman MA (1985). A reevaluation of non-hormonal cytotoxic chemotherapy in the treatment of prostatic carcinoma. J Clin Oncol 3: 827—841.

Feinberg AP (2001). Cancer epigenetics takes center stage. Proc Natl Acad Sci USA 98: 591—596.

Foster CS , Bostwick DG , Bonkhoff H. , Damber JE , van der Kwast T. , Montironi R. , Sakr WA ( 2000). Cellular and molecular pathology of prostate cancer precursors . Scand J Urol Nephrol Suppl 205: 19—43.

Foster CS , Ke Y. (1997). Stem cells in prostatic epithelia. Int J Exp Pathol 78: 311—329.

Gingrich JR , Greenberg NM (1996). A transgenic mouse prostate cancer model. Toxicol Pathol 24: 502—504.

Go YM , Patel RP , Maland MC , Park H. , Beckman JS , Darley-Usmar VM , Jo H. (1999). Evidence for peroxynitrite as a signaling molecule in fl owdependent activation of c-Jun NH(2)-terminal kinase. Am J Physiol 277 (4 Pt 2): H1647—1653.

Goktas D. , Crawford DE (1999). Optimal hormonal therapy for advanced prostate carcinoma. Semin Oncol 26: 162—173.

Han X. , Liehr JG , Bosland MC (1995). Induction of a DNA adduct detectable by 32P-postlabeling in the dorsolateral prostate of NBL/Cr rats treated with estradiol-17 beta and testosterone. Carcinogenesis 16: 951— 954.

Hegde P. , Qi R. , Abernathy K. , Gay C. , Dharap S. , Gaspard R. , Hughes JE , Snesrud E. , Lee N. , Quackenbush J. (2000). A concise guide to cDNA microarray analysis. Biotechniques 29: 548—550, 552—554, 556.

Ho SM , Lee KF , Lane K. ( 1997). Neoplastic transformation of the prostate. In: Prostate: Basic and Clinical Aspect , Naz RK (ed). CRC Press, Boca Raton, FL, pp 74—114.

Ho SM , Roy D. (1994). Sex hormone-induced nuclear DNA damage and lipid peroxidation in the dorsolateral prostates of Noble rats. Cancer Lett 84: 155—162.

Johnson P. , Ho S. , Welby C. , Hjelm M. , Ho CS , Patel T. , Townsend R. , Amess B. , Moyses C. , Parekh R. (1998). Application of Proteome Analysis to the Detection of “Hepatoma-Specific” Serum Proteins. Proceedings of the 89th Annual Meeting of the American Association for Cancer Research, vol 39, New Orleans, LA.

Jungblut PR , Zimny-Arndt U. , Zeindl-Eberhart E. , Stulik J. , Koupilova K. , Pleißner K-P. , Otto A. , Müller E-C. , Sokolowska-Köhler W. , Grabher G. , Stöffler G. (1999). Proteomics inhuman disease: Cancer, heart and infectious diseases. Electrophoresis 20: 2100—2110.

Ke Y. , Jing C. , Barraclough R. , Smith P. , Davies MP , Foster CS (1997). Elevated expression of calcium-binding protein p9Ka is associated with increasing malignant characteristics of rat prostate carcinoma cells. Int J Cancer 71: 832—837.

Kennedy S. (2001). Proteomic profi ling from human samples: The body fl uid alternative. Toxicol Lett 120: 379—384.

Kononen J. , Bubendorf L. , Kallioniemi A. , Barlund M. , Schraml P. , Leighton S. , Torhorst J. , Mihatsch M. , Sauter G. , Kallioniemi OP (1998). Tissue microarrays for high-throughput molecular profi ling of tumor specimens. Nat Med 4: 844—847.

Leav I. , Ho SM , Ofner P. , Merk FB , Kwan PW , Damassa D. (1988). Biochemical alterations in sex hormone-induced hyperplasia and dysplasia of the dorsolateral prostates of Noble rats. J Natl Cancer Inst 80: 1045—1053.

Li X. , De Sarno P. , Song L. , Beckman JS , Jope RS ( 1998). Peroxynitrite modulates tyrosine phosphorylation and phosphoinositide signalling in human neuroblastoma SH-SY5Y cells: Attenuated effects in human 1321N1 astrocytoma cells. Biochem J 331( Pt 2): 599—606.

Lucia MS , Bostwick DG , Bosland M. , Cockett ATK , Knapp DW , Leav I. , Pollard M. , Rinker-Schaeffer C. , Shirai T. , Watkins BA (1998). Work group I: Rodent models of prostate cancer . Prostate 36: 49—55.

Moyses C. (1999). Pharmacogenetics, genomics, proteomics: The new frontiers in drug development. Int J Pharm Med 13: 197—202.

Olumi AF , Grossfeld GD , Hayward SW , Carroll PR , Tlsty TD , Cunha GR (1999). Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium. Cancer Res 59: 5002—5011.

Page MJ , Amess B. , Reid TR , Parekh R. , Herath A. , Brusten L. , Zvelebil MJ , Stein RC , Waterfi eld MD , Davies SC , O'Hare MJ (1999). Proteomic defi nition of normal human luminal and myoepithelial breast cells purifi ed from reduction mammoplasties. Proc Natl Acad Sci USA 96: 12589— 12594.

Patel AC , Anna CH ( 2000). Hypermethylation of the p16 (Ink4a) promoter in B6C3F1 mouse primary lung adenocarcinoma s and mouse lung cell lines. Carcinogenesis 21: 1691—1700.

Ripple G. , Wilding G. (1999). Drug development in prostate cancer. Semin Oncol 26: 217—226.

Suwa T. , Nyska A. , Haseman JK , Mahler JF , Maronpot RR (2001). Background lesions and sectioning of male accessory sex organs in B6C3F1 mouse. Toxicol Pathol 30.

Suwa T. , Nyska A. , Peckham JC , Hailey JR , Mahler JF , Haseman JK , Maronpot RR (2001). A retrospective analysis of background lesions and tissue accountability for male accessory sex organs in Fischer-344 rats . Toxicol Pathol 29: 467—478.

Tam NN , Chung SS , Lee DT , Wong YC ( 2000). Aberrant expression of hepatocyte growth factor and its receptor, c-met, during sex hormone-induced prostatic carcinogenesis in the Noble rat. Carcinogenesis 21: 2183—2191.

Simone NS , Bonner RF , Gillespie JW , Emmert-Buck MR , Liotta LA (1998). Laser-capture microdissection: Opening the microscopic frontier to molecular analysis. Trends Genet 14: 272—276.

Tennant TR , Kim H. , Sokoloff M. , Rinker-Schaeffer CW (2000). The Dunning model. Prostate 43: 295—302.

van Weerden MW , Romijn JC (2000). Use of nude mouse xenograft models in prostate cancer research. Prostate 43: 263—271.

Vercoutter-Edouart AS , Czeszak X. , Crepin M. , Lemoine J. , Boilly B. , Le Bourhis X. , Peyrat JP , Hondermarck H. (2001). Proteomic detection of change s in protein synthesis induced by fibroblast growth factor-2 in MCF-7 human breast cancer cells. Exp Cell Res 262: 59—68.

Wang Y. , Hayward SW , Donjacour AA , Young P. , Jacks T. , Sage J. , Dahiya R. , Cardiff R. , Day ML , Cunha GR (2000). Hormonal carcinogenesis of the Rb-knockout mouse prostate. Cancer Res 69: 6008—6017.